Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
株式のランク #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
株価
$0.04406501
最終同期: 2024-07-09
時価総額
$23.47M
変化(1日)
-0.48%
変化(1年)
0.00%
SE
取引 InDex Pharmaceuticals Holding AB (publ) (INDEX)

カテゴリー

InDex Pharmaceuticals Holding AB (publ)(INDEX)の配当利回りの履歴
InDex Pharmaceuticals Holding AB (publ)(銘柄コード: INDEX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
InDex Pharmaceuticals Holding AB (publ)(INDEX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)